152 related articles for article (PubMed ID: 14648709)
21. Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition.
Kaaks R; Rinaldi S; Key TJ; Berrino F; Peeters PH; Biessy C; Dossus L; Lukanova A; Bingham S; Khaw KT; Allen NE; Bueno-de-Mesquita HB; van Gils CH; Grobbee D; Boeing H; Lahmann PH; Nagel G; Chang-Claude J; Clavel-Chapelon F; Fournier A; Thiébaut A; González CA; Quirós JR; Tormo MJ; Ardanaz E; Amiano P; Krogh V; Palli D; Panico S; Tumino R; Vineis P; Trichopoulou A; Kalapothaki V; Trichopoulos D; Ferrari P; Norat T; Saracci R; Riboli E
Endocr Relat Cancer; 2005 Dec; 12(4):1071-82. PubMed ID: 16322344
[TBL] [Abstract][Full Text] [Related]
22. Low Free Testosterone and Prostate Cancer Risk: A Collaborative Analysis of 20 Prospective Studies.
Watts EL; Appleby PN; Perez-Cornago A; Bueno-de-Mesquita HB; Chan JM; Chen C; Cohn BA; Cook MB; Flicker L; Freedman ND; Giles GG; Giovannucci E; Gislefoss RE; Hankey GJ; Kaaks R; Knekt P; Kolonel LN; Kubo T; Le Marchand L; Luben RN; Luostarinen T; Männistö S; Metter EJ; Mikami K; Milne RL; Ozasa K; Platz EA; Quirós JR; Rissanen H; Sawada N; Stampfer M; Stanczyk FZ; Stattin P; Tamakoshi A; Tangen CM; Thompson IM; Tsilidis KK; Tsugane S; Ursin G; Vatten L; Weiss NS; Yeap BB; Allen NE; Key TJ; Travis RC
Eur Urol; 2018 Nov; 74(5):585-594. PubMed ID: 30077399
[TBL] [Abstract][Full Text] [Related]
23. Serum androgens: associations with prostate cancer risk and hair patterning.
Demark-Wahnefried W; Lesko SM; Conaway MR; Robertson CN; Clark RV; Lobaugh B; Mathias BJ; Strigo TS; Paulson DF
J Androl; 1997; 18(5):495-500. PubMed ID: 9349747
[TBL] [Abstract][Full Text] [Related]
24. High levels of circulating insulin-like growth factor-I increase prostate cancer risk: a prospective study in a population-based nonscreened cohort.
Stattin P; Rinaldi S; Biessy C; Stenman UH; Hallmans G; Kaaks R
J Clin Oncol; 2004 Aug; 22(15):3104-12. PubMed ID: 15284261
[TBL] [Abstract][Full Text] [Related]
25. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women.
Eliassen AH; Missmer SA; Tworoger SS; Spiegelman D; Barbieri RL; Dowsett M; Hankinson SE
J Natl Cancer Inst; 2006 Oct; 98(19):1406-15. PubMed ID: 17018787
[TBL] [Abstract][Full Text] [Related]
26. Relationships of serum androgens and estrogens to prostate cancer risk: results from a prospective study in Finland.
Dorgan JF; Albanes D; Virtamo J; Heinonen OP; Chandler DW; Galmarini M; McShane LM; Barrett MJ; Tangrea J; Taylor PR
Cancer Epidemiol Biomarkers Prev; 1998 Dec; 7(12):1069-74. PubMed ID: 9865423
[TBL] [Abstract][Full Text] [Related]
27. Serum testosterone and the risk of prostate cancer: potential implications for testosterone therapy.
Parsons JK; Carter HB; Platz EA; Wright EJ; Landis P; Metter EJ
Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2257-60. PubMed ID: 16172240
[TBL] [Abstract][Full Text] [Related]
28. The role of sex hormone-binding globulin and testosterone in the risk of incident metabolic syndrome.
Haring R; Völzke H; Spielhagen C; Nauck M; Wallaschofski H
Eur J Prev Cardiol; 2013 Dec; 20(6):1061-8. PubMed ID: 22711969
[TBL] [Abstract][Full Text] [Related]
29. Both total testosterone and sex hormone-binding globulin are independent risk factors for metabolic syndrome: results from Fangchenggang Area Male Health and Examination Survey in China.
Zhang J; Huang X; Liao M; Gao Y; Tan A; Yang X; Zhang H; Mo L; Zhang Y; Lu Z; Wu C; Hu Y; Mo Z
Diabetes Metab Res Rev; 2013 Jul; 29(5):391-7. PubMed ID: 23463406
[TBL] [Abstract][Full Text] [Related]
30. Vasectomy and prostate cancer: results from a multiethnic case-control study.
John EM; Whittemore AS; Wu AH; Kolonel LN; Hislop TG; Howe GR; West DW; Hankin J; Dreon DM; Teh CZ
J Natl Cancer Inst; 1995 May; 87(9):662-9. PubMed ID: 7538594
[TBL] [Abstract][Full Text] [Related]
31. Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis.
Gann PH; Ma J; Giovannucci E; Willett W; Sacks FM; Hennekens CH; Stampfer MJ
Cancer Res; 1999 Mar; 59(6):1225-30. PubMed ID: 10096552
[TBL] [Abstract][Full Text] [Related]
32. The protective effect of diabetes mellitus against prostate cancer: role of sex hormones.
Baradaran N; Ahmadi H; Salem S; Lotfi M; Jahani Y; Baradaran N; Mehrsai AR; Pourmand G
Prostate; 2009 Dec; 69(16):1744-50. PubMed ID: 19676082
[TBL] [Abstract][Full Text] [Related]
33. Influence of some biological indexes on sex hormone-binding globulin and androgen levels in aging or obese males.
Vermeulen A; Kaufman JM; Giagulli VA
J Clin Endocrinol Metab; 1996 May; 81(5):1821-6. PubMed ID: 8626841
[TBL] [Abstract][Full Text] [Related]
34. Circulating enterolactone and prostate cancer risk: a Nordic nested case-control study.
Stattin P; Adlercreutz H; Tenkanen L; Jellum E; Lumme S; Hallmans G; Harvei S; Teppo L; Stumpf K; Luostarinen T; Lehtinen M; Dillner J; Hakama M
Int J Cancer; 2002 May; 99(1):124-9. PubMed ID: 11948503
[TBL] [Abstract][Full Text] [Related]
35. Androgens, estrogens, and sex hormone-binding globulin in middle-aged men.
Longcope C; Goldfield SR; Brambilla DJ; McKinlay J
J Clin Endocrinol Metab; 1990 Dec; 71(6):1442-6. PubMed ID: 2229299
[TBL] [Abstract][Full Text] [Related]
36. Interrelationships between plasma testosterone, SHBG, IGF-I, insulin and leptin in prostate cancer cases and controls.
Kaaks R; Lukanova A; Rinaldi S; Biessy C; Söderberg S; Olsson T; Stenman UH; Riboli E; Hallmans G; Stattin P
Eur J Cancer Prev; 2003 Aug; 12(4):309-15. PubMed ID: 12883384
[TBL] [Abstract][Full Text] [Related]
37. Circulating levels of sex steroid hormones and risk of endometrial cancer in postmenopausal women.
Lukanova A; Lundin E; Micheli A; Arslan A; Ferrari P; Rinaldi S; Krogh V; Lenner P; Shore RE; Biessy C; Muti P; Riboli E; Koenig KL; Levitz M; Stattin P; Berrino F; Hallmans G; Kaaks R; Toniolo P; Zeleniuch-Jacquotte A
Int J Cancer; 2004 Jan; 108(3):425-32. PubMed ID: 14648710
[TBL] [Abstract][Full Text] [Related]
38. Corpulence is the crucial factor: association of testosterone and/or obesity with prostate cancer stage.
Jentzmik F; Schnoeller TJ; Cronauer MV; Steinestel J; Steffens S; Zengerling F; Al Ghazal A; Schrader MG; Steinestel K; Schrader AJ
Int J Urol; 2014 Oct; 21(10):980-6. PubMed ID: 24865433
[TBL] [Abstract][Full Text] [Related]
39. Serum concentrations of estrogens, sex hormone-binding globulin, and androgens and risk of breast cancer in postmenopausal women.
Adly L; Hill D; Sherman ME; Sturgeon SR; Fears T; Mies C; Ziegler RG; Hoover RN; Schairer C
Int J Cancer; 2006 Nov; 119(10):2402-7. PubMed ID: 16894564
[TBL] [Abstract][Full Text] [Related]
40. Serum testosterone and sex hormone-binding globulin concentrations and the risk of prostate carcinoma: a longitudinal study.
Heikkilä R; Aho K; Heliövaara M; Hakama M; Marniemi J; Reunanen A; Knekt P
Cancer; 1999 Jul; 86(2):312-5. PubMed ID: 10421267
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
